Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study. - Avallone, Gianluca; Bombelli, Andrea; Gargiulo, Luigi; Foti, Caterina; Trave, Ilaria; Rossi, Mariateresa; Magnaterra, Elisabetta; Pigliacelli, Flavia; Malagoli, Piergiorgio; Giacalone, Serena; Portarapillo, Antonio; Patruno, Cataldo; et al. (Dermatology & Therapy, 2025)